NEW YORK– Nov. 21, 2018 – Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.
-
Rouven Bergmann, chief financial officer, will present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, Nov. 28, 2018, in New York at 10 a.m. ET.
-
Tarek Sherif, chairman and chief executive officer, and Dr. Bergmann will present at the Nasdaq 39th Investor Conference on Wednesday, Dec. 5, 2018, in London at 9:45 a.m. GMT (4:45 a.m. ET.)
A live audio webcast and replay of each presentation will be available at http://investor.mdsol.com.
About Medidata
Medidata is leading the digital transformation of life sciences, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.mdsol.com
Medidata Solutions Contacts:
Investors:
Betsy Frank, 917-522-4620
or
Media:
Erik Snider, 646-362-2997